You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 14, 2025

Drug Price Trends for CHILD CETIRIZINE HCL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for CHILD CETIRIZINE HCL

Average Pharmacy Cost for CHILD CETIRIZINE HCL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CHILD CETIRIZINE HCL 1 MG/ML 70752-0104-06 0.03539 ML 2025-06-18
CHILD CETIRIZINE HCL 1 MG/ML 00904-6765-20 0.03539 ML 2025-06-18
CHILD CETIRIZINE HCL 1 MG/ML 70752-0104-06 0.03586 ML 2025-05-21
CHILD CETIRIZINE HCL 1 MG/ML 00904-6765-20 0.03586 ML 2025-05-21
CHILD CETIRIZINE HCL 1 MG/ML 70752-0104-06 0.03675 ML 2025-04-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Global Cetirizine Hydrochloride Market Analysis and Price Projections

Last updated: December 31, 2024

Market Overview

The global cetirizine hydrochloride market, which includes the drug commonly known as CHILD CETIRIZINE HCL, is a significant segment within the pharmaceutical industry. This market is driven by the increasing prevalence of allergic conditions such as allergic rhinitis, allergic conjunctivitis, and eczema.

Market Size and Growth

As of 2023, the global cetirizine hydrochloride market was valued at approximately USD 6.3 billion and is projected to grow at a Compounded Annual Growth Rate (CAGR) of 2.6% to reach USD 8.0 billion by 2034[4][5].

Key Drivers

  • Increasing Allergy Prevalence: The rising rates of allergic diseases worldwide are a major driver for the cetirizine hydrochloride market. For instance, more than 1 in 4 American children and over 1 in 3 American adults reported having a food allergy, eczema, or seasonal allergy in 2021[4].
  • Versatility and Safety Profile: Cetirizine hydrochloride's efficacy and safety profile make it a preferred choice for healthcare practitioners across various demographics, from pediatric to geriatric populations[4][5].
  • Generic Formulations: The introduction of generic versions has increased competition, driving down prices and making the drug more accessible to a broader range of consumers[4][5].

Regional Insights

North America

North America holds a dominant position in the global cetirizine hydrochloride market due to the high prevalence of hay fever and allergic conjunctivitis in the U.S. The region is expected to continue its significant revenue share due to the growing financial burden of allergic disorders on the population[1][4].

Asia Pacific

The Asia Pacific region is anticipated to witness the fastest revenue growth due to an aging population, greater disposable income, and rising allergy awareness. Developing nations in this region present considerable market potential for cetirizine hydrochloride[4].

Europe

The European market is expanding steadily, driven by an aging population and the rise in allergy prevalence among senior citizens[4].

Latin America and Middle East & Africa

Latin America is an emerging market with increasing healthcare spending due to a growing middle class, while the Middle East and Africa are in the developmental stages, with growth potential driven by improving healthcare infrastructure and rising allergy awareness[4][5].

Segment Analysis

Dosage Forms

The market is segmented by dosage forms, including tablets, syrup, and solutions. Tablets are popular among adults due to their convenience, while syrup and solutions are preferred for pediatric use due to their precise dosing and palatable formulations[5].

Age Group

The market is also segmented by age group into adults and pediatric populations. This segmentation reflects the diverse needs and preferences of consumers, allowing pharmaceutical companies to tailor their strategies and product formulations accordingly[5].

Application

Cetirizine hydrochloride is used to treat a variety of allergic conditions, including allergic rhinitis, allergic conjunctivitis, eczema, and others. This versatility ensures widespread adoption across different medical needs[5].

Price Projections and Budget Impact

Market Value

The global cetirizine hydrochloride market is expected to grow from USD 6.3 billion in 2024 to USD 8.0 billion by 2034, indicating a steady increase in market value[4].

Budget Impact

In the context of emergency department settings, the adoption of intravenous cetirizine hydrochloride has shown a positive budget impact. For example, the estimated net budget impact was $27,876, with potential additional revenue from earlier patient discharge and increased patient throughput[2].

Cost Variability

The cost of cetirizine hydrochloride can vary based on contractual agreements and wholesale acquisition costs (WAC). A markup of 3% is commonly applied, as per Medicare reimbursement rates[2].

Challenges and Opportunities

Regulatory Frameworks

Stringent laws and regulations can restrict market growth. However, improving healthcare infrastructure and rising allergy awareness in emerging regions present opportunities for market expansion[4].

New Medication Development

The threat of new medication development could slow the growth rate of cetirizine hydrochloride. However, its established safety profile and efficacy continue to make it a preferred treatment option[4].

Key Takeaways

  • The global cetirizine hydrochloride market is expected to grow at a CAGR of 2.6% from 2024 to 2034.
  • Increasing allergy prevalence and the drug's versatility are key drivers.
  • North America dominates the market, but the Asia Pacific region is expected to grow the fastest.
  • The market is segmented by dosage form, age group, and application.
  • Positive budget impact is observed in emergency department settings.
  • Regulatory frameworks and new medication development are potential challenges.

Frequently Asked Questions (FAQs)

1. What is the current market size of the global cetirizine hydrochloride market?

As of 2023, the global cetirizine hydrochloride market was valued at approximately USD 6.3 billion[4].

2. What is the projected growth rate of the cetirizine hydrochloride market?

The market is projected to grow at a CAGR of 2.6% from 2024 to 2034[4].

3. Which region dominates the cetirizine hydrochloride market?

North America holds a dominant position due to the high prevalence of allergic conditions in the U.S.[1][4].

4. What are the primary dosage forms of cetirizine hydrochloride?

The primary dosage forms include tablets, syrup, and solutions[5].

5. How does the introduction of generic formulations impact the market?

The introduction of generic formulations has increased competition, driving down prices and making the drug more accessible to a broader range of consumers[4][5].

Cited Sources:

  1. Coherent Market Insights - Cetirizine Hydrochloride Market Size and Trends
  2. AHDB Online - Budget Impact of Intravenous Cetirizine Hydrochloride for the Treatment of Acute Urticaria in the Emergency Department Setting
  3. BioSpace - Cetirizine Hydrochloride Market Key Players, Sales, Demand, Dynamic Forces, and Forecast 2029
  4. Prophecy Market Insights - Global Cetirizine Hydrochloride Market By Overview
  5. Reanin - Global Cetirizine Hydrochloride Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.